Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dishman Pharmaceuticals and Chemicals Ltd Recommends Final Dividend; Appointment Of Managing Director


Tuesday, 28 May 2013 05:54am EDT 

Dishman Pharmaceuticals and Chemicals Ltd announced that the Board of Directors of the Company at its meeting held on May 28, 2013, inter alia, has taken the following decisions: For the year 2012-13, the Board has recommended the final dividend at 60% (that is INR1.20 per equity share of INR2.00 each) on the paid-up equity share capital of the Company; Board has approved the appointment of whole time Director Mr. Arpit J. Vyas as Managing Director of the Company with effect from May 28, 2013 and since his present term expires on May 31, 2014, also approved his re-appointment as a Managing Director of the Company for a further period of five years with effect from June 01, 2014, subject to approval of the members at their ensuing Annual General Meeting scheduled to be held on July 30, 2013. 

Latest Developments for Dishman Pharmaceuticals and Chemicals Ltd

Company Quote

122.15
0.75 +0.62%
5:17am EDT